IRA Reality Check: Adapting Hub and Copay Programs to Ensure Patient Access and Affordability
Live Event | September 17, 2024 | 1pm EDT
Register to join us live or get on-demand access
The IRA is here to stay. How can brand and access leaders adapt?
The IRA (Inflation Reduction Act) is much more than a passing threat. As key provisions are proceeding, it is looking less likely that the IRA will be challenged in congress. Manufacturers may need to consider multiple different adjustments to bolster branded patient support programming.
As the industry grapples with the realities of price negotiations, inflation penalties, and Part D redesign, manufacturers must adapt their hub and copay programs to ensure continued patient access and affordability.
The IRA may have rewritten the rulebook, but with strategic adaptations and a patient-centric focus, manufacturers can continue to deliver effective patient support programs that meet the evolving needs of patients in this new era of drug pricing.
Join ConnectiveRx for an in-depth look at how brand and access leaders can continue to offer robust patient support despite the challenges brought about by the IRA.
Register for live and on-demand access!
Featuring a conversation with:
Partner, Healthcare Privacy and Cybersecurity
William Sarraille is a senior member of the Healthcare practice group and a nationally-recognized lawyer in healthcare law. Bill concentrates on a variety of healthcare matters, including Medicare and Medicaid reimbursement, coverage and coding, pharmaceutical price reporting, issues related to the marketing and promotion of pharmaceuticals and medical devices, internal investigations, clinical research issues, Stark and Anti-Kickback Law analyses, Medicare and Medicaid audits, healthcare acquisitions and due diligence, compliance program audits, managed care matters, healthcare contracts, administrative litigation, legislative matters, privacy and security, coverage for new devices and services, the Foreign Corrupt Practices Act, international compliance and healthcare contracting, the representation of witnesses and companies before Congressional Committees, and the defense of healthcare criminal and False Claims Act matters. He has also been lead counsel in important Administrative Procedure Act matters concerning Medicare coverage, and reimbursement, patient assistance, the Anti-Kickback statute, price reporting, and risk adjustment issues. Bill has defended clients in some of the largest healthcare fraud investigations brought by the U.S. Government.